Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair-Reference-Cited by-同舟云学术

Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair

Published:2016-03-25 Issue:2 Volume:139 Page:467-479
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Harnicek Dominique¹,Kampmann Eric²,Lauber Kirsten³,Hennel Roman³,Cardoso Martins Ana Sofia¹,Guo Yang⁴,Belka Claus³,Mörtl Simone⁵,Gallmeier Eike⁶,Kanaar Roland⁷⁸,Mansmann Ulrich⁹,Hucl Tomas¹⁰,Lindner Lars H.²,Hiddemann Wolfgang²,Issels Rolf D.²

Affiliation:

1. Hämatologikum of the Helmholtz Center Munich, German Research Center for Environmental Health; Munich Germany

2. Department of Medicine III; University Hospital Grosshadern, University of Munich; Munich Germany

3. Department of Radiation Oncology; University Hospital Grosshadern, University of Munich; Munich Germany

4. Department of Medicine II; University Hospital Grosshadern, University of Munich; Munich Germany

5. Institute of Radiation Biology, Helmholtz Zentrum München, German Research Center for Environmental Health; Munich Germany

6. Department of Internal Medicine; Philipps University of Marburg; Marburg Germany

7. Department of Genetics, Cancer Genomics Netherlands; Erasmus Medical Center; Rotterdam The Netherlands

8. Department of Radiation Oncology; Erasmus Medical Center; Rotterdam The Netherlands

9. Institute of Medical Informatics, Biostatistics, and Epidemiology, Campus Grosshadern, University of Munich; Munich Germany

10. Department of Gastroenterology and Hepatology; Institute for Clinical and Experimental Medicine; Prague Czech Republic

Funder

Helmholtz-Gemeinschaft

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study;Samuels;Ann Oncol,2013

2. A review of trabectedin (ET-743): a unique mechanism of action;D'Incalci;Mol Cancer Ther,2010

3. Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin;Herrero;Cancer Res,2006

4. BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients;Laroche-Clary;Br J Cancer,2015

5. Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study;Schöffski;Eur J Cancer,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor boost the efficacy of photothermal therapy to TNBC through enhanced DNA damage and inhibited homologous recombination repair;Drug Delivery and Translational Research;2024-07-02

2. Hyperthermieverfahren in der Onkologie;InFo Hämatologie + Onkologie;2024-07

3. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy;Molecules;2024-01-09

4. Therapy induced tumor cell senescence: mechanisms and ways to overcome;Биохимия;2023-01-15

5. Therapy-Induced Tumor Cell Senescence: Mechanisms and Circumvention;Biochemistry (Moscow);2023-01